Write For Us

Drug to treat agitation in Alzheimer’s patients approved in Canada

Sponsored Post Vitamin D2 Canada Persia
34 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

ava
Published
Health Canada has green lit a drug previously approved for schizophrenia and depression to treat symptoms of agitation in Alzheimer’s patients – a common symptom of the disease.

Rexulti (brexpiprazole) oral tablets manufactured by Otsuka Pharmaceutical Canada Inc. and Lundbeck Canada Inc. were issued a Notice of Compliance by the regulator, according to a company release Wednesday.

This approval was given after three 12-week randomized, double-blind, placebo-controlled studies, the release said. Global's Katherine Ward explains.

For more info, please go to https://globalnews.ca/news/10249782/alzheimers-agitation-symptoms-canada-drug-approval/

Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Health #Alzheimers #Dementia
Category
U.S. & Canada
Tags
global news, health news, health
Sign in or sign up to post comments.
Be the first to comment